Objectives This study aims to examine the capacity of anti-Müllerian hormone (AMH) to
predict cumulative live birth rate (CLBR) following IVF/ICSI within 36 months since start of …

Purpose Anti-Müllerian hormone (AMH) is used as a marker for ovarian reserve. Since 2011,
the standard test for AMH has been the Beckman Coulter Generation (Gen) II assay …

Purpose To determine if diminished ovarian reserve (measured by maternal antimullerian
hormone (AMH) levels), is associated with fetal aneuploidy (determined by prenatal …

The objective of the present commentary is to suggest that epidemiologists explore the use
of anti-Müllerian hormone (AMH) as a new measurement tool in fecundability studies. The …

Introduction The correlation between ovarian reserve and infertility remains unclear. Albeit
poorly predictive of pregnancy success in in vitro fertilization cycles, serum anti‐Müllerian …

Objective To assess anti‐Müllerian hormone (AMH) levels as a marker of early abortion in
the first trimester among women younger than 35 years. Methods Prospective study of …

BACKGROUND Anti-Müllerian hormone (AMH) levels are used to evaluate the ovarian
reserve. AMH serum concentrations have recently been studied among women attending …

Summary Context In approximately 5–8% patients with primary ovarian insufficiency (POI),
the disease is caused by an autoimmune process made evident by the appearance of …

To assess if anti-mullerian hormone (AMH) concentrations decrease during the third
trimester of pregnancy and puerperium and whether this is correlated to gestational diabetes …

Introduction Anti-Müllerian hormone (AMH) is a member of the transforming growth factor-β
superfamily, playing a role in sexual differentiation and recruitment. Since a correlation …